Abbott Laboratories (ABT) stock forecast for 2026. Forecast tables and graphs.







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Abbott Laboratories (ABT) stock forecast for 2026

Updated: April 18, 2024 (08:42)

Sector: Healthcare

The share price of Abbott Laboratories (ABT) now

What analysts predict: $126.74
52-week High/Low: $121.04 / $88.8

50/200 Day Moving Average: $114.55 / $106.71

This figure corresponds to the Average Price over the previous 50/200 days. For Abbott Laboratories stocks, the 50-day moving average is the resistance level today.

For Abbott Laboratories stocks, the 200-day moving average is the resistance level today.

Are you interested in Abbott Laboratories stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Abbott Laboratories stock price in 2026. How much will one Abbott Laboratories share be worth in 2026? Is it worth taking profit / loss on ABT stock now or waiting? What are analysts' forecasts for Abbott Laboratories stock?

We forecast Abbott Laboratories stock performance using neural networks based on historical data on ABT stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Abbott Laboratories stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Abbott Laboratories analysts is $126.74. Today 200 Day Moving Average is the support level (106.71 $). 50 Day Moving Average is the resistance level (114.55 $).




Historical and forecast chart of Abbott Laboratories stock

The chart below shows the historical price of Abbott Laboratories stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ABT stock price can be found in the table below.


Sell or Buy Abbott Laboratories (ABT) stocks? Analytic Experts Forecasting...

We present you the most up-to-date and complete review of analytical trend forecasts and views on the ABT stock market. Experts share their opinions on what to expect.

Abbott Laboratories manufactures drugs, medical devices and diagnostic tools – tests for immunity and blood tests that are used in clinics and hospitals in N countries. The first HIV test was developed by Abbott.

Business publications and major stock indices recognize Abbott Laboratories’ contributions: Fortune magazine has ranked the company as one of the most respected in the world every year since 1984.

The company was founded in 1888. The University of Michigan graduate Wallace Abbott worked as a medical practitioner and opened his own pharmacy. He introduced a new way of using alkaloids of medicinal plants: he formed granules from them with micro doses. Treatment with these granules helped patients because the doses of the drug were accurate and the effect was predictable and consistent.

Official site of the company

Abbott Laboratories (ABT) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 97.78 95.90 103.72 7.54 %
Feb 99.11 95.70 101.33 5.56 %
Mar 99.50 96.72 105.31 8.16 %
Apr 104.44 99.26 110.96 10.54 %
May 105.86 100.10 110.26 9.22 %
Jun 112.13 108.09 116.07 6.88 %
Jul 112.48 105.92 115.00 7.90 %
Aug 106.55 100.49 112.77 10.88 %
Sep 104.24 98.32 107.16 8.25 %
Oct 100.66 97.60 104.60 6.70 %
Nov 96.87 93.70 102.38 8.48 %
Dec 93.85 90.02 98.58 8.68 %

Abbott Laboratories information and performance

Abbott Laboratories Address

100 ABBOTT PARK ROAD, ABBOTT PARK, IL, US

Market Capitalization: 189 499 015 000 $

Market capitalization of the Abbott Laboratories is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABT shares in the company outstanding by the market price of one share.

EBITDA: 10 463 000 000 $

EBITDA of Abbott Laboratories is earnings before interest, income tax and depreciation of assets.

PE Ratio: 33.4

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 5.99

Price/earnings to growth

DPS: 2.08

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0201

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 3.27

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.55
Quarterly Revenue Growth YOY: 0.015
Trailing PE: 33.4

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 23.64

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.928

Enterprise Value (EV) /Revenue

EV To EBITDA: 18.75

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1735180000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Abbott Laboratories price target for 2026 by month


Target values for the price of one Abbott Laboratories share for Jan 2026.

The weighted average target price per Abbott Laboratories share in Jan 2026 is: 97.78.
In Jan, the Negative dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 7.542% volatility is expected.
Pessimistic target level: 95.90
Optimistic target level: 103.72

Target values for the price of one Abbott Laboratories share for Feb 2026.

The weighted average target price per Abbott Laboratories share in Feb 2026 is: 99.11.
In Feb, the Positive dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 5.556% volatility is expected.
Pessimistic target level: 95.70
Optimistic target level: 101.33

Target values for the price of one Abbott Laboratories share for Mar 2026.

The weighted average target price per Abbott Laboratories share in Mar 2026 is: 99.50.
In Mar, the Positive dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 8.163% volatility is expected.
Pessimistic target level: 96.72
Optimistic target level: 105.31

Target values for the price of one Abbott Laboratories share for Apr 2026.

The weighted average target price per Abbott Laboratories share in Apr 2026 is: 104.44.
In Apr, the Positive dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 10.542% volatility is expected.
Pessimistic target level: 99.26
Optimistic target level: 110.96

Target values for the price of one Abbott Laboratories share for May 2026.

The weighted average target price per Abbott Laboratories share in May 2026 is: 105.86.
In May, the Positive dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 9.216% volatility is expected.
Pessimistic target level: 100.10
Optimistic target level: 110.26

Target values for the price of one Abbott Laboratories share for Jun 2026.

The weighted average target price per Abbott Laboratories share in Jun 2026 is: 112.13.
In Jun, the Positive dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 6.878% volatility is expected.
Pessimistic target level: 108.09
Optimistic target level: 116.07

Target values for the price of one Abbott Laboratories share for Jul 2026.

The weighted average target price per Abbott Laboratories share in Jul 2026 is: 112.48.
In Jul, the Positive dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 7.903% volatility is expected.
Pessimistic target level: 105.92
Optimistic target level: 115.00

Target values for the price of one Abbott Laboratories share for Aug 2026.

The weighted average target price per Abbott Laboratories share in Aug 2026 is: 106.55.
In Aug, the Negative dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 10.884% volatility is expected.
Pessimistic target level: 100.49
Optimistic target level: 112.77

Target values for the price of one Abbott Laboratories share for Sep 2026.

The weighted average target price per Abbott Laboratories share in Sep 2026 is: 104.24.
In Sep, the Negative dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 8.249% volatility is expected.
Pessimistic target level: 98.32
Optimistic target level: 107.16

Target values for the price of one Abbott Laboratories share for Oct 2026.

The weighted average target price per Abbott Laboratories share in Oct 2026 is: 100.66.
In Oct, the Negative dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 6.698% volatility is expected.
Pessimistic target level: 97.60
Optimistic target level: 104.60

Target values for the price of one Abbott Laboratories share for Nov 2026.

The weighted average target price per Abbott Laboratories share in Nov 2026 is: 96.87.
In Nov, the Negative dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 8.479% volatility is expected.
Pessimistic target level: 93.70
Optimistic target level: 102.38

Target values for the price of one Abbott Laboratories share for Dec 2026.

The weighted average target price per Abbott Laboratories share in Dec 2026 is: 93.85.
In Dec, the Negative dynamics for Abbott Laboratories shares will prevail with possible monthly volatility of 8.682% volatility is expected.
Pessimistic target level: 90.02
Optimistic target level: 98.58



Abbott Laboratories (ABT) stock dividend

Abbott Laboratories last paid dividends on 04/12/2024. The next scheduled payment will be on 05/15/2024. The amount of dividends is $2.08 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.